Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-25-020368
Filing Date
2025-03-05
Accepted
2025-03-05 08:16:59
Documents
100
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0231646-10k_protara.htm   iXBRL 10-K 1472979
2 FIRST CERTIFICATE OF AMENDMENT TO INDUCEMENT PLAN OF THE REGISTRANT DATED MARCH ea023164601ex10-36_protara.htm EX-10.36 5539
3 INSIDER TRADING POLICY ea023164601ex19-1_protara.htm EX-19.1 47014
4 LIST OF SUBSIDIARIES ea023164601ex21-1_protara.htm EX-21.1 3678
5 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea023164601ex23-1_protara.htm EX-23.1 5259
6 CERTIFICATION ea023164601ex31-1_protara.htm EX-31.1 11023
7 CERTIFICATION ea023164601ex31-2_protara.htm EX-31.2 11214
8 CERTIFICATION ea023164601ex32-1_protara.htm EX-32.1 5819
9 GRAPHIC image_001.jpg GRAPHIC 28070
10 GRAPHIC image_002.jpg GRAPHIC 21063
11 GRAPHIC image_003.jpg GRAPHIC 24586
  Complete submission text file 0001213900-25-020368.txt   7745507

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE tara-20241231.xsd EX-101.SCH 77374
13 XBRL CALCULATION FILE tara-20241231_cal.xml EX-101.CAL 58220
14 XBRL DEFINITION FILE tara-20241231_def.xml EX-101.DEF 318172
15 XBRL LABEL FILE tara-20241231_lab.xml EX-101.LAB 636231
16 XBRL PRESENTATION FILE tara-20241231_pre.xml EX-101.PRE 354982
102 EXTRACTED XBRL INSTANCE DOCUMENT ea0231646-10k_protara_htm.xml XML 768400
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

EIN.: 204580525 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36694 | Film No.: 25708938
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)